SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Ginkgo Bioworks Holdings, Inc. DNA NYSE

NYSE • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Ginkgo Bioworks Holdings, Inc. (DNA) 有 12 个已识别的同行可供比较在 Healthcare 板块. 同行包括 ARVN, ATXS, AVBP, AVRO, CWBR, ELEV 等.

DNA 的市值为 $482.39M, 而同行平均市值为 $583.71M.

同行与相似公司 — DNA

$10.97 -0.27% $704.54M

Astria Therapeutics, Inc.

$12.58 0.00% $718.13M

ArriVent BioPharma, Inc. Common Stock

$29.41 +6.40% $1.3B

$1.40 -1.41% $5.24M

$0.41 0.00% $1.19M

Elevation Oncology, Inc.

$0.37 -2.12% $21.63M

Enveric Biosciences, Inc.

$2.03 +4.10% $1.21M

Hepion Pharmaceuticals, Inc.

$0.04 -19.58% $448.54K

Iovance Biotherapeutics, Inc.

$3.82 +4.95% $1.27B

MBX Biosciences, Inc. Common Stock

$32.96 +0.46% $1.11B

MeiraGTx Holdings plc

$11.25 -0.35% $916.27M

Maravai LifeSciences Holdings, Inc.

$3.50 +6.71% $961.62M

其他人也在看

Vir Biotechnology, Inc.

ArriVent BioPharma, Inc. Common Stock

Iovance Biotherapeutics, Inc.

MBX Biosciences, Inc. Common Stock

Maravai LifeSciences Holdings, Inc.

MeiraGTx Holdings plc

Astria Therapeutics, Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言